Search

Search Constraints

You searched for: Author/Creator Elbast, Walid

Search Results

2. European Bioanalysis Forum: recommendation for dealing with internal standard variability. (October 2014)

3. Fevipiprant has a low risk of influencing co-medication pharmacokinetics: Impact on simvastatin and rosuvastatin in different SLCO1B1 genotypes. (August 2019)

4. Pharmacokinetics, Safety, and Tolerability of Fevipiprant (QAW039), a Novel CRTh2 Receptor Antagonist: Results From 2 Randomized, Phase 1, Placebo‐Controlled Studies in Healthy Volunteers. Issue 4 (28th March 2016)